The global sepsis diagnostics market size is predicted to reach USD 1.03 billion by 2027 according to a new study by Polaris Market Research. The report “Sepsis Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Product (Instruments, Blood Culture Media, Assay Kits & Reagents, Software); By Technology (Microbiology, Molecular Diagnostics, Biomarkers, Immunoassays, Flow Cytometry); By Pathogen (Bacterial Sepsis, Fungal Sepsis, Others); By Testing Type (Laboratory Testing, PoC Testing); By Regions; Segment Forecast, 2020 – 2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The key factors responsible for the market growth include innovations in biomarker-based sepsis diagnosis; growing medical attention towards ill effects of sepsis and its economic burden; and the development of technologically advanced rapid PoC diagnosis systems. Moreover, the favorable reimburse scenario in developed economies and burgeoning healthcare infrastructure in low and middle-income countries is expected to propel market growth.
The market is fragmented based on product, technology, pathogen, type, and region. In terms of product, the market is segmented into instruments, blood culture media, assay kits and reagents, and software. Based on technology, the market is further bifurcated into microbiology, molecular diagnostics, biomarkers, immunoassays, and flow cytometry. Based on pathogen, the market is classified as bacterial sepsis, fungal sepsis, and others. The type segment is further divided into laboratory testing, and PoC testing.
Download Sample Copy : https://www.polarismarketresearch.com/industry-analysis/global-sepsis-diagnostics-market/request-for-sample
Segment Highlight
- The blood culture media segment accounted for the largest revenue share of the global market as it is used in maximum cases for diagnosis. However, the kits & reagents market segment is expected to witness fastest growth over the forecast period.
- Microbiology technology segment is expected to account for the largest revenue share by the end of 2027 as the technology aids in quantitative identification and detection of microorganisms through culture media tests
- Laboratory testing segment is expected to witness significant growth over the forecast period on account of the increasing number of blood cultures conducted in laboratories across the globe
- North America region is dominating the market, holding a significant market share throughout the forecast period. The presence of major players in the region, industry-academia collaboration, and intellectual capability of the U.S. are major factors responsible for the region’s growth
List of Key Players
- bioMérieux
- Becton Dickinson
- Danaher Corporation
- Abbott Laboratories
- Thermo Fisher Scientific
- EKF Diagnostics
- Roche Diagnostics
- Others
For Further Insights and Segment-Specific Information, Contact a Market Analyst at : https://www.polarismarketresearch.com/industry-analysis/global-sepsis-diagnostics-market/request-for-customization
